Excimer Laser–Assisted Removal of Embedded Inferior Vena Cava Filters
- 1 October 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Interventions
- Vol. 6 (5), 560-566
- https://doi.org/10.1161/circinterventions.113.000665
Abstract
Background—: Although chronically implanted inferior vena cava filters may result in filter-related morbidity, there is currently no routine option for removing such filters when they become firmly embedded along the vena cava endothelium. Methods and Results—: During a 3-year period, 100 consecutive patients were prospectively enrolled in a single-center study. There were 42 men and 58 women (mean age, 46 years; limits, 18–76 years). Retrieval indications included filter-related acute inferior vena cava thrombosis, chronic inferior vena cava occlusion, and pain from retroperitoneal or bowel penetration. Filter retrieval was also performed to prevent risks from prolonged implantation and to potentially eliminate the need for lifelong anticoagulation. After standard methods failed, photothermal tissue ablation was attempted with a laser sheath powered by a 308-nm xenon chloride excimer laser. Applied forces were recorded with a digital tension meter before and during laser activation. Laser-assisted retrieval was successful in 98.0% (95% confidence interval [CI], 93.0%–99.8%) with mean implantation of 855 days (limits, 37–6663 days; >18 years). The following filter types were encountered in this study: Günther-Tulip (n=34), Celect (n=12), Option (n=17), Optease (n=20, 1 failure), TrapEase (n=6, 1 failure), Simon-Nitinol (n=1), 12F Stainless Steel Greenfield (n=4), and Titanium Greenfield (n=6). The average force during failed standard retrievals was 7.2 versus 4.6 pounds during laser-assisted retrievals ( P <0.0001). The major complication rate was 3.0% (95% CI, 0.6%–8.5%), the minor complication rate was 7.0% (95% CI, 0.3%–13.9%), and there were 4 adverse events (2 coagulopathic hemorrhages, 1 renal infarction, and 1 cholecystitis; 4.0%; 95% CI, 1.1%–9.9%) at mean follow-up of 500 days (limits, 84–1079 days). Scar tissue ablation was histologically confirmed in 96.0% (95% CI, 89.9%–98.9%). Successful retrieval allowed cessation of anticoagulation in 30 of 30 (100%) patients and alleviated morbidity in 23 of 24 patients (96%). Conclusions—: Excimer laser–assisted removal is effective in removing embedded inferior vena cava filters refractory to standard retrieval and high force. This method can be safely used to prevent and alleviate filter-related morbidity. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01158482.Keywords
This publication has 23 references indexed in Scilit:
- Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filtersJournal of Vascular Surgery, 2010
- Excimer Laser–assisted Retrieval of Günther Tulip Vena Cava Filters: A Pilot Study in a Canine ModelJournal of Vascular and Interventional Radiology, 2010
- Emergency endovascular repair for traumatic injury of the inferior vena cava☆European Journal of Cardio-Thoracic Surgery, 2005
- Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary EmbolismCirculation, 2005
- Inferior vena cava endograft to control surgically inaccessible hemorrhageJournal of Vascular Surgery, 2003
- Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trialJournal of the American College of Cardiology, 1999
- A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein ThrombosisThe New England Journal of Medicine, 1998
- Excimer laser induced bubble: Dimensions, theory, and implications for laser angioplastyLasers in Surgery and Medicine, 1996
- Effect of force on ablation depth for a XeCl excimer laser beam delivered by an optical fiber in contact with arterial tissue under salineLasers in Surgery and Medicine, 1992
- XeCl laser ablation of atherosclerotic aorta: Optical properties and energy pathwaysLasers in Surgery and Medicine, 1992